GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicover AB (FRA:5M0B) » Definitions » Debt-to-EBITDA

Medicover AB (FRA:5M0B) Debt-to-EBITDA : 3.88 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medicover AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medicover AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €246 Mil. Medicover AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €828 Mil. Medicover AB's annualized EBITDA for the quarter that ended in Mar. 2024 was €277 Mil. Medicover AB's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 3.88.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Medicover AB's Debt-to-EBITDA or its related term are showing as below:

FRA:5M0B' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.42   Med: 3.23   Max: 5.24
Current: 3.95

During the past 10 years, the highest Debt-to-EBITDA Ratio of Medicover AB was 5.24. The lowest was 2.42. And the median was 3.23.

FRA:5M0B's Debt-to-EBITDA is ranked worse than
67.13% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs FRA:5M0B: 3.95

Medicover AB Debt-to-EBITDA Historical Data

The historical data trend for Medicover AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicover AB Debt-to-EBITDA Chart

Medicover AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.73 2.42 2.78 4.35 3.90

Medicover AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.98 3.64 4.04 3.47 3.88

Competitive Comparison of Medicover AB's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Medicover AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medicover AB's Debt-to-EBITDA falls into.



Medicover AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medicover AB's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(229.1 + 774.6) / 257.4
=3.90

Medicover AB's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(245.6 + 828.2) / 276.8
=3.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Medicover AB  (FRA:5M0B) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Medicover AB Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medicover AB's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicover AB (FRA:5M0B) Business Description

Traded in Other Exchanges
Address
Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, SE-102 46
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.

Medicover AB (FRA:5M0B) Headlines

No Headlines